|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.985
|
|
|
|
fibroblast migration
|
GO:0010761 |
21 |
0.913
|
|
|
|
estrogen metabolic process
|
GO:0008210 |
8 |
0.800
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.798
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.796
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.753
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.733
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.726
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.721
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.700
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.681
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.643
|
|
|
|
face development
|
GO:0060324 |
38 |
0.612
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.589
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.588
|
|
|
|
leydig cell differentiation
|
GO:0033327 |
10 |
0.581
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.561
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.534
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.514
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.467
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.464
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.445
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.442
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.438
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.426
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.366
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.360
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.349
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.339
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.329
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.313
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.312
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.311
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.302
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.293
|
|
|
|
androgen metabolic process
|
GO:0008209 |
11 |
0.269
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.260
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.255
|
|
|
|
fat pad development
|
GO:0060613 |
6 |
0.241
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.240
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.238
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.214
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.203
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.201
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.199
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.195
|
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.194
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.191
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.190
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.189
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.183
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.181
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.180
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.179
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.179
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.172
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.171
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.170
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.166
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.164
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.158
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.157
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.155
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.154
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.150
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.146
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.138
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.138
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.133
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.131
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.129
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.129
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.127
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.127
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.126
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.126
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.125
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.120
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.120
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.117
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.117
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.117
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.114
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.110
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.108
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.108
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.106
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.105
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.103
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.102
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.101
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.101
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.100
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.099
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.098
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.096
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.095
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.094
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.093
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.091
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.089
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.088
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.087
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.086
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.084
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.084
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.084
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.084
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.082
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.081
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.081
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.080
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.080
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.079
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.079
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.078
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.076
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.074
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.073
|
|
|
|
luteinization
|
GO:0001553 |
8 |
0.073
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.073
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.072
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.072
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.072
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.072
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.071
|
Human |
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.071
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.070
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.069
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.069
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.069
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.069
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.068
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.067
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.066
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.066
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.066
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.065
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.064
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.063
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.063
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.063
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.063
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.062
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.062
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.062
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.062
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.061
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.061
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.061
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.061
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.060
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.060
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.060
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.059
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.059
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.059
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.058
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.058
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.058
|
|
|
|
muscle cell migration
|
GO:0014812 |
19 |
0.057
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.057
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.056
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.056
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.056
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.055
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.055
|
Human |
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.055
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.055
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.055
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.054
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.054
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.054
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.054
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.053
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.053
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.053
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.052
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.052
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.052
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.052
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.052
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.052
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.051
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.051
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.051
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.051
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.051
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.050
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.050
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.050
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.050
|
|
|
|
regulation of developmental pigmentation
|
GO:0048070 |
14 |
0.050
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.050
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.049
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.049
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.049
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.049
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.048
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.048
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.048
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.047
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.047
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.046
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.046
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.046
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
0.046
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.046
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.046
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.045
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.045
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.045
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.045
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.045
|
|
|
|
translation
|
GO:0006412 |
93 |
0.045
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.044
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.044
|
|
|
|
b cell apoptotic process
|
GO:0001783 |
19 |
0.043
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.043
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.043
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.043
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.043
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.043
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.043
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.043
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.042
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.042
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.042
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.041
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.041
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.040
|
|
|
|
response to macrophage colony stimulating factor
|
GO:0036005 |
3 |
0.040
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.040
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.040
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.040
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.040
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.040
|
Human |
|
|
t cell activation
|
GO:0042110 |
289 |
0.039
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.039
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.039
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.039
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.039
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.038
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.038
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.038
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.038
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.038
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.037
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.037
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.037
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.037
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.037
|
Human |
|
|
cell adhesion
|
GO:0007155 |
329 |
0.037
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.037
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.037
|
|
|
|
cellular response to macrophage colony stimulating factor stimulus
|
GO:0036006 |
3 |
0.037
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.037
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.037
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.036
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.036
|
|
|
|
activation of mapkkk activity
|
GO:0000185 |
1 |
0.036
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.036
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.036
|
|
|
|
dendritic cell cytokine production
|
GO:0002371 |
3 |
0.036
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.036
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.036
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.036
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.036
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.036
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.035
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.035
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.035
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.035
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.035
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.035
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.034
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.034
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.034
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.034
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.034
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.034
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.034
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.034
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.034
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.034
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.033
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.033
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.033
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.033
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.033
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.033
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.033
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.033
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.033
|
|
|
|
regulation of p38mapk cascade
|
GO:1900744 |
3 |
0.033
|
|
|
|
b cell receptor signaling pathway
|
GO:0050853 |
20 |
0.032
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.032
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.032
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.032
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.032
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.032
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.032
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.031
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.031
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.031
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.031
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.031
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.031
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.031
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.031
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.031
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.031
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.031
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.030
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.030
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.030
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.030
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.030
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.030
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.030
|
|
|
|
immature b cell differentiation
|
GO:0002327 |
10 |
0.030
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.029
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.029
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.029
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.029
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.029
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.029
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.029
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.029
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.029
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.029
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.029
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.029
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.029
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.029
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.029
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.029
|
|
|
|
sphingolipid catabolic process
|
GO:0030149 |
7 |
0.029
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.028
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.028
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.028
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.028
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.028
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.028
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.028
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.028
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.028
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.028
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.028
|
|
|
|
negative regulation of lymphocyte differentiation
|
GO:0045620 |
32 |
0.028
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.027
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.027
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.027
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.027
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.027
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.027
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.027
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.027
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.027
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.027
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.027
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.026
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.026
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.026
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.026
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.026
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.026
|
|
|
|
calcium ion import
|
GO:0070509 |
14 |
0.026
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.026
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.026
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.026
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.026
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.026
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.025
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.025
|
|
|
|
positive regulation of osteoclast differentiation
|
GO:0045672 |
15 |
0.025
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.025
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.025
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.025
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.025
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.025
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.025
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.025
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.024
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.024
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.024
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.024
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.024
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.024
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.024
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.024
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.024
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.023
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.023
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.023
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.023
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.023
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.023
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.023
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.023
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.023
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.023
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.023
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.023
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.023
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.023
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.023
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.023
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.023
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.022
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.022
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.022
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.022
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.022
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.022
|
|
|
|
cellular response to interleukin 15
|
GO:0071350 |
2 |
0.022
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.022
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.022
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.022
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.022
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.022
|
|
|
|
cellular response to nitric oxide
|
GO:0071732 |
4 |
0.022
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.022
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.022
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.022
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.021
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.021
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.021
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.021
|
|
|
|
negative regulation of cellular response to insulin stimulus
|
GO:1900077 |
16 |
0.021
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.021
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.021
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.021
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.021
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.021
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.021
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.021
|
|
|
|
centrosome separation
|
GO:0051299 |
4 |
0.021
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.021
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.021
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.021
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.020
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.020
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.020
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.020
|
|
|
|
glycosphingolipid metabolic process
|
GO:0006687 |
18 |
0.020
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.020
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.020
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.020
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.020
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.020
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.020
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.020
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.020
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.020
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.020
|
|
|
|
regulation of vacuole organization
|
GO:0044088 |
4 |
0.020
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.020
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.020
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.019
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.019
|
|
|
|
pyridine nucleotide biosynthetic process
|
GO:0019363 |
4 |
0.019
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.019
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.019
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.019
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.019
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.019
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.019
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.019
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.019
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.019
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.019
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.019
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.019
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.019
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.019
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.019
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.019
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.019
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.019
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.018
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.018
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.018
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.018
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.018
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.018
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.018
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.018
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.018
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.018
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.018
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.018
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.018
|
|
